S&P 500   3,768.25 (-0.72%)
DOW   30,814.26 (-0.57%)
QQQ   311.86 (-0.79%)
AAPL   127.14 (-1.37%)
MSFT   212.65 (-0.17%)
FB   251.36 (+2.33%)
GOOGL   1,727.62 (-0.19%)
AMZN   3,104.25 (-0.74%)
TSLA   826.16 (-2.23%)
NVDA   514.38 (-2.58%)
BABA   243.46 (+0.20%)
CGC   33.39 (-3.55%)
GE   11.33 (-2.83%)
MU   80.72 (-0.71%)
AMD   88.21 (-2.84%)
T   29.17 (-0.41%)
NIO   56.27 (-7.56%)
F   9.83 (-3.34%)
ACB   12.04 (+0.67%)
BA   204.32 (-2.66%)
DIS   171.44 (-1.15%)
NFLX   497.98 (-0.58%)
GILD   63.33 (+1.49%)
S&P 500   3,768.25 (-0.72%)
DOW   30,814.26 (-0.57%)
QQQ   311.86 (-0.79%)
AAPL   127.14 (-1.37%)
MSFT   212.65 (-0.17%)
FB   251.36 (+2.33%)
GOOGL   1,727.62 (-0.19%)
AMZN   3,104.25 (-0.74%)
TSLA   826.16 (-2.23%)
NVDA   514.38 (-2.58%)
BABA   243.46 (+0.20%)
CGC   33.39 (-3.55%)
GE   11.33 (-2.83%)
MU   80.72 (-0.71%)
AMD   88.21 (-2.84%)
T   29.17 (-0.41%)
NIO   56.27 (-7.56%)
F   9.83 (-3.34%)
ACB   12.04 (+0.67%)
BA   204.32 (-2.66%)
DIS   171.44 (-1.15%)
NFLX   497.98 (-0.58%)
GILD   63.33 (+1.49%)
S&P 500   3,768.25 (-0.72%)
DOW   30,814.26 (-0.57%)
QQQ   311.86 (-0.79%)
AAPL   127.14 (-1.37%)
MSFT   212.65 (-0.17%)
FB   251.36 (+2.33%)
GOOGL   1,727.62 (-0.19%)
AMZN   3,104.25 (-0.74%)
TSLA   826.16 (-2.23%)
NVDA   514.38 (-2.58%)
BABA   243.46 (+0.20%)
CGC   33.39 (-3.55%)
GE   11.33 (-2.83%)
MU   80.72 (-0.71%)
AMD   88.21 (-2.84%)
T   29.17 (-0.41%)
NIO   56.27 (-7.56%)
F   9.83 (-3.34%)
ACB   12.04 (+0.67%)
BA   204.32 (-2.66%)
DIS   171.44 (-1.15%)
NFLX   497.98 (-0.58%)
GILD   63.33 (+1.49%)
S&P 500   3,768.25 (-0.72%)
DOW   30,814.26 (-0.57%)
QQQ   311.86 (-0.79%)
AAPL   127.14 (-1.37%)
MSFT   212.65 (-0.17%)
FB   251.36 (+2.33%)
GOOGL   1,727.62 (-0.19%)
AMZN   3,104.25 (-0.74%)
TSLA   826.16 (-2.23%)
NVDA   514.38 (-2.58%)
BABA   243.46 (+0.20%)
CGC   33.39 (-3.55%)
GE   11.33 (-2.83%)
MU   80.72 (-0.71%)
AMD   88.21 (-2.84%)
T   29.17 (-0.41%)
NIO   56.27 (-7.56%)
F   9.83 (-3.34%)
ACB   12.04 (+0.67%)
BA   204.32 (-2.66%)
DIS   171.44 (-1.15%)
NFLX   497.98 (-0.58%)
GILD   63.33 (+1.49%)
Log in
OTCMKTS:CCEL

Cryo-Cell International Stock Forecast, Price & News

$7.80
0.00 (0.00 %)
(As of 01/15/2021 12:00 AM ET)
Add
Compare
Today's Range
$7.78
Now: $7.80▼
$7.84
50-Day Range
$7.33
MA: $7.53▼
$7.80
52-Week Range
$4.52
Now: $7.80▼
$9.93
Volume84,412 shs
Average Volume12,413 shs
Market Capitalization$58.86 million
P/E Ratio19.50
Dividend YieldN/A
Beta0.29
Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, kidney, ALS, wound healing, and auto-immune diseases. The company also manufactures and sells PrepaCyte CB processing system, a technology used to process umbilical cord blood stem cells. It stores approximately 500,000 cord blood and cord tissue stem cells worldwide. The company markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. Cryo-Cell International, Inc. was founded in 1989 and is headquartered in Oldsmar, Florida.

MarketRank™

Overall MarketRank™

1.21 out of 5 stars

Medical Sector

672nd out of 1,480 stocks

Miscellaneous Health & Allied Services, Not Elsewhere Classified Industry

7th out of 15 stocks

Analyst Opinion: 0.0Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 2.5Valuation: 1.3 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Stock Exchange OTCMKTS
Industry Miscellaneous health & allied services, not elsewhere classified
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:CCEL
Previous Symbol
CUSIPN/A
CIK862692
Webwww.cryo-cell.com
Phone813-749-2100
Employees87

Debt

Debt-to-Equity RatioN/A
Current Ratio1.16
Quick Ratio1.08

Price-To-Earnings

Trailing P/E Ratio19.50
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$31.80 million
Price / Sales1.85
Cash Flow$0.38 per share
Price / Cash Flow20.80
Book Value($0.89) per share
Price / Book-8.76

Profitability

EPS (Most Recent Fiscal Year)N/A
Net Income$2.29 million
Net Margins10.39%
Return on Equity-58.74%
Return on Assets7.30%

Miscellaneous

Outstanding Shares7,546,000
Market Cap$58.86 million
Next Earnings Date2/25/2021 (Estimated)
OptionableNot Optionable
$7.80
0.00 (0.00 %)
(As of 01/15/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive CCEL News and Ratings via Email

Sign-up to receive the latest news and ratings for CCEL and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Cryo-Cell International (OTCMKTS:CCEL) Frequently Asked Questions

How has Cryo-Cell International's stock price been impacted by Coronavirus (COVID-19)?

Cryo-Cell International's stock was trading at $7.20 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, CCEL shares have increased by 8.6% and is now trading at $7.82.
View which stocks have been most impacted by COVID-19.

What stocks does MarketBeat like better than Cryo-Cell International?

Wall Street analysts have given Cryo-Cell International a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Cryo-Cell International wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Cryo-Cell International's next earnings date?

Cryo-Cell International is scheduled to release its next quarterly earnings announcement on Thursday, February 25th 2021.
View our earnings forecast for Cryo-Cell International.

How were Cryo-Cell International's earnings last quarter?

Cryo-Cell International, Inc. (OTCMKTS:CCEL) posted its quarterly earnings data on Tuesday, October, 15th. The company reported $0.13 EPS for the quarter. The company earned $8.20 million during the quarter. Cryo-Cell International had a net margin of 10.39% and a negative return on equity of 58.74%.
View Cryo-Cell International's earnings history.

Who are some of Cryo-Cell International's key competitors?

Some companies that are related to Cryo-Cell International include GreenVision Acquisition (GRNV), Emmaus Life Sciences (EMMA), Baudax Bio (BXRX), Pacific Health Care Organization (PFHOD), Caladrius Biosciences (CLBS), BioRestorative Therapies (BRTX), BioRestorative Therapies (BRTXQ), Connectyx Technologies Holdings Group (CTYX), Pacific Health Care Organization (PFHO), American Caresource (GNOW), Hybrid Energy (HYBE) and QMed (QMED).
View all of CCEL's competitors.

What other stocks do shareholders of Cryo-Cell International own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cryo-Cell International investors own include NVIDIA (NVDA), Overstock.com (OSTK), Avid Technology (AVID), The Boeing (BA), Enphase Energy (ENPH), OPKO Health (OPK), Riot Blockchain (RIOT), Aldeyra Therapeutics (ALDX), Alimera Sciences (ALIM) and Allena Pharmaceuticals (ALNA).

Who are Cryo-Cell International's key executives?

Cryo-Cell International's management team includes the following people:
  • Mr. David I. Portnoy, Chairman & Co-CEO (Age 57, Pay $652.09k)
  • Mr. Mark L. Portnoy, Co-Chief Exec. Officer (Age 56, Pay $519k)
  • Ms. Jill M. Taymans, CFO & VP of Fin. (Age 50, Pay $201.5k)
  • Mr. Oleg Mikulinsky, Chief Information Officer (Age 47, Pay $258.33k)
  • Dr. Merri Buff Mair, Medical Director & Member of Medical & Scientific Team

What is Cryo-Cell International's stock symbol?

Cryo-Cell International trades on the OTCMKTS under the ticker symbol "CCEL."

How do I buy shares of Cryo-Cell International?

Shares of CCEL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Cryo-Cell International's stock price today?

One share of CCEL stock can currently be purchased for approximately $7.82.

How big of a company is Cryo-Cell International?

Cryo-Cell International has a market capitalization of $59.01 million and generates $31.80 million in revenue each year. Cryo-Cell International employs 87 workers across the globe.

What is Cryo-Cell International's official website?

The official website for Cryo-Cell International is www.cryo-cell.com.

How can I contact Cryo-Cell International?

Cryo-Cell International's mailing address is 700 Brooker Creek Boulevard Suite 1800, Oldsmar FL, 34677. The company can be reached via phone at 813-749-2100.

This page was last updated on 1/15/2021 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.